Parkinson's Disease
1st Edition
Molecular and Therapeutic Insights From Model Systems
Secure Checkout
Personal information is secured with SSL technology.Free Shipping
Free global shippingNo minimum order.
Description
Parkinson’s disease is the second most prevalent neurodegenerative disease and is characterized by the irreversible loss of dopamine neurons. Despite its high prevalence in society and many decades of research, the origin of the pathogenesis and the molecular determinants involved in the disorder has remained elusive. Confounding this issue is the lack of experimental models that completely recapitulate the disease state. The identification of a number of genes thought to play a role in the cell death, and development of both toxin and genetic models to explore the function of the genes both in unaffected and diseased cells are now providing new insights into the molecular basis of the neurodegeneration, as well as therapeutic approaches. In this reference, we will describe the advances and the advantages that various invertebrates, cell culture, rodents, and mammals provide in the identification of the molecular components and mechanisms involved in the cell death, and outline the opportunities that these systems provide in drug discovery.
Key Features
- Comprehensive and critical assessment of the utility of various model systems to identify the molecular components and pathways involved in Parkinson’s disease
- Describes the power of toxin and genetic models to identify novel therapeutic targets and compounds that can be used in PD
- Current overviews of current status of PD research and discovery from bench-to-bedside
- Provides novel insights and views on where the future of PD research may lead
- Provides a powerful teaching tool and template to explore the utility of model systems to identify molecular pathways, molecular targets, and therapeutics that are applicable to a variety of neurological diseases
Readership
Researchers and graduate students in neuroscience and neurology. Industry, pharmaceutical, libraries, and clinicians will also be interested
Details
- No. of pages:
- 686
- Language:
- English
- Copyright:
- © Academic Press 2008
- Published:
- 31st July 2008
- Imprint:
- Academic Press
- Hardcover ISBN:
- 9780123740281
- eBook ISBN:
- 9780080559582
About the Editors
Richard Nass
Affiliations and Expertise
Assistant Professor of Pharmacology and Toxicology, Center for Environmental Health, Stark Neuroscience Research Institute, Indiana University School of Medicine in Indianapolis, IN
Serge Przedborski
Affiliations and Expertise
Professor of Neurology & Pathology and Cell Biology, Center for Neurobiology and Behavior, Columbia University, NY, U.S.A.
Ratings and Reviews
Request Quote
Tax Exemption
Elsevier.com visitor survey
We are always looking for ways to improve customer experience on Elsevier.com.
We would like to ask you for a moment of your time to fill in a short questionnaire, at the end of your visit.
If you decide to participate, a new browser tab will open so you can complete the survey after you have completed your visit to this website.
Thanks in advance for your time.